Depression FAQ

The DSM-5-TR lists nine symptoms: depressed mood, loss of interest or pleasure (anhedonia), changes in appetite or weight, sleep changes, psychomotor changes, fatigue, feelings of worthlessness or guilt, reduced ability to think or concentrate, and recurrent thoughts of death or suicide. A major depressive episode requires at least five symptoms for two weeks, including at least one of the first two.

From Symptoms of depression (overview)

Five or more of the nine DSM-5-TR symptoms during the same two-week period, with at least one being depressed mood or anhedonia, and with meaningful effect on daily life. Fewer symptoms can still warrant treatment when they are persistent or impairing.

From Symptoms of depression (overview)

Yes. Some people present with sadness and tearfulness, others with irritability or anger (especially in adolescents), others with flatness and anhedonia, others with fatigue and physical complaints. Older adults often present with cognitive symptoms or somatic complaints rather than overt sadness.

From Symptoms of depression (overview)

When symptoms last more than two weeks, when they interfere with work, school, or relationships, or when there are any thoughts of suicide. A primary care visit is a reasonable starting point. For severe symptoms or active suicidal thoughts, call or text 988 or go to the nearest emergency department.

From Symptoms of depression (overview)

Yes. A meaningful share of patients with depression describe flatness rather than sadness, including a loss of pleasure (anhedonia) and a muted response to events that would normally move them. It is recognized in the DSM-5-TR criteria for major depressive disorder.

From Emotional numbness

Sadness is a present feeling. Anhedonia is the absence of feeling, especially the absence of pleasure or interest. Patients with anhedonia often say food has no taste, music does not register, and time with loved ones feels distant.

From Emotional numbness

Often yes. Anhedonia can be slower to improve than mood, and certain antidepressants and behavioral activation strategies are particularly aimed at it. A clinician can help match treatment to the symptom that is most prominent.

From Emotional numbness

They can. Around 40 to 60 percent of patients on SSRIs report some degree of emotional blunting, distinct from the numbness of depression itself (Goodwin et al., Journal of Affective Disorders, 2017). It usually improves with a dose change, a switch to bupropion or vortioxetine, or addition of a second agent. Telling the prescriber what you mean by numbness, and when it started, helps separate symptom from side effect.

From Emotional numbness

Yes. Emotional numbness is a core feature of post-traumatic stress disorder, can occur in dissociative disorders, and is reported with chronic substance use. A clinician will ask about trauma history, substance use, and the timing of the numbness in relation to other symptoms before settling on a diagnosis.

From Emotional numbness

Low motivation is one of the most common and disruptive symptoms of depression. The intention to act is often intact; the energy and reward signal needed to start are not. This is not laziness and is not a character problem.

From Low motivation

Behavioral activation, a structured therapy that schedules small, valued activities and tracks the effect, has strong evidence for the motivation symptoms of depression. Antidepressant medication can also help, particularly when low energy and anhedonia are prominent.

From Low motivation

Start smaller than feels reasonable: a five-minute walk, one dish washed, one short text to a friend. Action tends to come before motivation, not after it. Track what helps for a week. If symptoms persist for more than two weeks or affect work, school, or relationships, talk to a clinician.

From Low motivation

No. Procrastination is delaying a task you still expect to enjoy or value. The low motivation of depression is a flattened reward signal: the activity itself no longer feels worth starting, even when the person knows it matters. Calling it laziness misreads a symptom and tends to delay treatment.

From Low motivation

Yes, modestly and reliably. A 2024 BMJ network meta-analysis of 218 trials found walking, jogging, yoga, and strength training all produced clinically meaningful reductions in depressive symptoms, with effect sizes in the moderate range. Even short, scheduled bouts (10 to 20 minutes) help reinitiate the activity-reward loop that depression flattens.

From Low motivation

Fatigue in depression involves changes in sleep architecture, circadian rhythm, appetite and nutrition, activity level, and inflammatory signaling. The result is a heavy, body-deep tiredness that sleep does not fix. About 90 percent of patients with major depression report meaningful fatigue.

From Fatigue and depression

Ordinary tiredness improves with rest. The fatigue of depression often does not. Patients describe waking unrefreshed, feeling effort in routine tasks, and losing the sense that activity is restorative.

From Fatigue and depression

Treating the underlying depression is the main lever. Sleep regularity, light morning exposure, and graded physical activity have evidence as adjuncts. Medical conditions that cause fatigue, including thyroid disease, anemia, and obstructive sleep apnea, are worth ruling out.

From Fatigue and depression

Bupropion, an activating antidepressant that targets dopamine and norepinephrine, is often chosen when fatigue and low energy dominate. SNRIs such as duloxetine and venlafaxine are also reasonable options. Sedating agents like mirtazapine, paroxetine, or amitriptyline can worsen daytime fatigue and are usually avoided for this presentation.

From Fatigue and depression

Both involve persistent, unrefreshing tiredness, but they are not the same. ME/CFS is defined by post-exertional malaise (a delayed worsening after even small activity), unrefreshing sleep, and cognitive symptoms, with depression as an exclusion when it fully accounts for symptoms (IOM, 2015). The conditions can overlap, and a careful history is needed to plan treatment.

From Fatigue and depression

Both insomnia and hypersomnia occur in depression. Early-morning awakening (waking around 3 to 5 a.m. and being unable to return to sleep) is the classic pattern. Difficulty falling asleep, frequent night awakenings, and sleeping much more than usual are also common.

From Sleep changes

Often yes. Sleep is one of the symptoms that tracks closely with mood. Sedating antidepressants, sleep-focused cognitive behavioral therapy (CBT-I), and attention to sleep timing can all help. Persistent insomnia after mood improves deserves separate attention.

From Sleep changes

A sleep study is worth considering when there are signs of obstructive sleep apnea (loud snoring, witnessed pauses in breathing, daytime sleepiness despite adequate time in bed) or when insomnia does not respond to first-line treatment. Untreated sleep apnea both mimics and worsens depression.

From Sleep changes

For chronic insomnia, yes. Cognitive behavioral therapy for insomnia (CBT-I) matches or exceeds prescription sleep medications in head-to-head trials and produces durable benefit after treatment ends, while medications work only while they are taken (Mitchell et al., BMC Family Practice, 2012). The American College of Physicians recommends CBT-I as first-line treatment for chronic insomnia in adults.

From Sleep changes

Often, yes. New early-morning awakening, a sudden need to sleep much more than usual, or insomnia in someone with a history of depression are common early relapse signals and are worth flagging to a clinician promptly. Tracking sleep alongside mood is a low-effort way to catch a returning episode early.

From Sleep changes

Depression changes appetite in either direction. Some patients lose interest in food and lose weight without trying. Others eat more, often carbohydrate-heavy foods, and gain weight. Either pattern is recognized in the DSM-5-TR criteria.

From Appetite changes

Unintentional weight change of more than five percent of body weight in a month, in either direction, is one of the symptoms clinicians track. It is also a reason to check for medical contributors such as thyroid disease and to review medications.

From Appetite changes

Some do. Mirtazapine often increases appetite. Bupropion and fluoxetine tend to be weight-neutral or modestly weight-reducing. Many SSRIs are weight-neutral in the short term and can be associated with modest weight gain over years. Choice of medication takes this into account.

From Appetite changes

Severe appetite loss with rapid weight loss, dehydration, or electrolyte changes is medically urgent and may need inpatient care. In milder cases, structured small meals, high-calorie liquids, and treatment of the underlying depression usually restore intake. A clinician can also rule out medical causes such as cancer, hyperthyroidism, or gastrointestinal disease.

From Appetite changes

A persistent fear of weight gain, restrictive eating, binge episodes, purging, or body-image preoccupation points toward an eating disorder rather than depressive appetite change. Eating disorders and depression often co-occur and benefit from a clinician with experience in both.

From Appetite changes

Anhedonia is the loss of interest or pleasure in activities that were previously enjoyed. It is one of the two core symptoms of major depressive disorder; the other is depressed mood. Either one can anchor the diagnosis.

From Loss of interest

A clinician will ask what the person used to enjoy, what has changed, and how often the loss of interest occurs. Validated scales such as the Snaith-Hamilton Pleasure Scale are sometimes used. The clinical question is whether the change is consistent and whether it affects daily life.

From Loss of interest

Yes. Behavioral activation, certain antidepressants (including those with stronger dopaminergic effect), and exercise all have evidence for anhedonia. Anhedonia can be slower to respond than mood, and a treatment plan often addresses it specifically.

From Loss of interest

Boredom is situational and lifts when something genuinely engaging appears. The loss of interest in depression is broader and more durable: even activities the person knows they loved no longer pull them in. The DSM-5-TR requires the change be present most of the day, nearly every day, for at least two weeks before it counts toward a diagnosis.

From Loss of interest

Yes. Reduced libido is part of the broader loss-of-interest picture in depression and is one of the symptoms most often underreported. Antidepressants, particularly SSRIs and SNRIs, can also cause sexual side effects, so a clinician will ask whether the change predates the medication. Bupropion and mirtazapine have lower rates of sexual side effects when this is a concern.

From Loss of interest

No. Honest reflection on past actions is part of being human. The guilt of depression is different: it is harsh, persistent, often disproportionate to the facts, and resistant to evidence. The DSM-5-TR lists feelings of worthlessness or excessive or inappropriate guilt as one symptom of a major depressive episode.

From Guilt and worthlessness

A useful test is whether the guilt responds to evidence. Ordinary guilt about a specific action eases with reflection, conversation, and time. Depressive guilt does not, and it tends to spread to areas where the person has done nothing wrong. Discussing the pattern with a clinician helps.

From Guilt and worthlessness

Usually yes. As mood, sleep, and energy improve, the harshness of self-judgment tends to soften. Cognitive behavioral therapy directly targets the thinking patterns that drive depressive guilt.

From Guilt and worthlessness

Guilt that includes fixed, unshakable beliefs of having committed unforgivable acts, of being responsible for events the person could not have caused, or of deserving punishment or death points to psychotic depression. Psychotic features change the treatment plan (often an antidepressant plus an antipsychotic, or ECT) and warrant urgent psychiatric evaluation.

From Guilt and worthlessness

Anxiety-driven self-criticism is usually future-focused (worrying about doing something wrong) and responds to reassurance. Depressive guilt is past-focused, treats reassurance as further evidence of failure, and tends to globalize ("I am bad") rather than localize ("I did something bad"). Both can coexist, and a careful history sorts them out.

From Guilt and worthlessness

Yes. Cognitive symptoms in depression include slowed thinking, reduced concentration, smaller working memory, and slower processing speed. They are measurable on neuropsychological testing and contribute meaningfully to disability.

From Brain fog

In most patients, cognitive symptoms improve as mood improves. A subset has residual cognitive symptoms that persist into recovery and benefit from cognitive remediation, attention to sleep, and physical activity.

From Brain fog

In adults under 60 with a clear mood disorder, the cognitive changes are usually depression-related and improve with treatment. When cognitive symptoms are out of proportion to mood, when there are concerns about progressive memory loss, or when the person is older, a fuller cognitive evaluation is reasonable.

From Brain fog

Pseudodementia describes cognitive impairment caused by depression that can look like early dementia, particularly in older adults. The pattern usually includes prominent slowness, "I do not know" answers, and effort-dependent deficits, and it improves substantially when the depression is treated. A clinician familiar with geriatric psychiatry can usually distinguish it from a true neurodegenerative process, sometimes with neuropsychological testing.

From Brain fog

They help indirectly, by treating the underlying depression, and a few have direct evidence for cognition. Vortioxetine has shown benefit on processing speed and executive function in randomized trials independent of mood improvement (McIntyre et al., International Journal of Neuropsychopharmacology, 2014). Sleep regularity, aerobic exercise, and reducing alcohol all amplify cognitive recovery.

From Brain fog

Yes. In adults, irritability is a recognized presentation of depression. In children and adolescents, the DSM-5-TR allows irritable mood to substitute for depressed mood in the diagnostic criteria. Patients often describe a short fuse that does not match the day.

From Irritability

Persistent or episodic irritability with reduced need for sleep, racing thoughts, increased goal-directed activity, or inflated self-esteem deserves an evaluation for bipolar disorder. The treatment for bipolar depression differs from the treatment for unipolar depression.

From Irritability

Standard antidepressant and psychotherapy treatment for depression usually reduces irritability. When irritability is prominent and does not respond, a clinician may reassess the diagnosis and consider mood-stabilizing strategies.

From Irritability

No. Persistent, severe irritability in children that occurs across settings, with frequent temper outbursts, may meet criteria for disruptive mood dysregulation disorder (DMDD), a separate DSM-5-TR diagnosis. Anxiety disorders, ADHD, autism spectrum disorder, sleep disorders, and trauma can also drive irritability. A pediatric mental health evaluation sorts these out.

From Irritability

In a minority of patients, particularly young people, SSRIs can produce activation symptoms in the first weeks of treatment, including irritability, restlessness, and disrupted sleep. The FDA black-box warning on antidepressants in patients under 25 reflects related concerns about increased suicidal thinking. New or worsening irritability after starting an antidepressant should be reported to the prescriber promptly.

From Irritability

Suicidal thoughts sit on a spectrum. Passing wishes that life would end without a plan or intent are common in depression and are a reason to talk to a clinician promptly. Active intent, a plan, access to means, or a recent attempt is an emergency: call or text 988, call 911, or go to the nearest emergency department.

From Suicidal thoughts (symptom page)

About 12.3 million U.S. adults reported serious thoughts of suicide in the past year (SAMHSA, 2022). Among patients with major depressive disorder, the lifetime prevalence is substantially higher. Talking about suicidal thoughts does not increase risk; it is the first step in a safety plan.

From Suicidal thoughts (symptom page)

A safety plan is a brief written plan made with a clinician that lists warning signs, internal coping strategies, people and places that provide distraction, people to ask for help, professional contacts, and steps to make the environment safer (including reducing access to firearms and stockpiled medication). The Stanley-Brown Safety Plan is the most widely used template.

From Suicidal thoughts (symptom page)

Stay with them, listen without arguing or rushing to fix, and ask directly whether they have a plan or access to means. Help reduce access to firearms and stockpiled medication, and connect them to 988, their clinician, or an emergency department if there is intent or a plan. Asking about suicide does not increase risk; it opens the door to help.

From Suicidal thoughts (symptom page)

Yes. The most consistent and largest-effect suicide prevention finding is restricting access to lethal means, particularly firearms. Studies of household firearm storage, bridge barriers, and pesticide regulation all show meaningful reductions in suicide deaths without comparable increases by other methods (Mann et al., JAMA, 2005; Yip et al., Lancet, 2012). Reducing access during a crisis buys the time most people need for the urge to pass.

From Suicidal thoughts (symptom page)

The DSM-5-TR recognizes several depressive disorders, including major depressive disorder, persistent depressive disorder, premenstrual dysphoric disorder, disruptive mood dysregulation disorder, and depressive disorder due to another medical condition. Specifiers for major depressive disorder include peripartum onset, seasonal pattern, melancholic features, atypical features, anxious distress, and psychotic features.

From Types of depression (overview)

Major depressive disorder is defined by discrete episodes of at least two weeks. Persistent depressive disorder, formerly called dysthymia, requires depressed mood for most of the day, more days than not, for at least two years in adults. A substantial share of patients have both at once, sometimes called double depression.

From Types of depression (overview)

Bipolar depression looks identical to unipolar major depressive disorder during the depressive episodes. The difference is the rest of the picture: people with bipolar disorder also have, at some point in life, episodes of mania (bipolar I) or hypomania (bipolar II). Standard antidepressants alone can destabilize bipolar disorder, which is why getting the diagnosis right matters.

From Types of depression (overview)

The type of depression shapes the choice of treatment. Postpartum depression has medications studied specifically in that population. Seasonal depression responds to bright light therapy. Bipolar depression usually requires a mood stabilizer rather than an antidepressant alone. Treatment-resistant depression has its own evidence-based options including TMS, esketamine, and ECT.

From Types of depression (overview)

Major depressive disorder is a clinical diagnosis defined by at least two weeks of persistent low mood or loss of interest, plus other symptoms (sleep, appetite, energy, concentration, guilt, psychomotor changes, or thoughts of death), with meaningful effect on daily life. It is not the same as a difficult week or a hard season.

From Major depressive disorder

Untreated, an average major depressive episode lasts about six to nine months. With treatment, most people see meaningful improvement in eight to twelve weeks. Some episodes are shorter. Some last longer. Roughly half of patients who recover have one or more future episodes in their lifetime (APA Practice Guideline, 2010).

From Major depressive disorder

Major depressive disorder is defined by discrete episodes of at least two weeks. Persistent depressive disorder, formerly called dysthymia, requires depressed mood for most of the day, more days than not, for at least two years in adults. A meaningful share of patients have both at once, which is sometimes called double depression.

From Major depressive disorder

About one in three people reach full remission on the first medication tried, and roughly half show a meaningful response. Most patients need a change in dose, a switch in medication, or an addition. With persistent care, most people reach remission. The STAR*D trial is the best-known source for these numbers.

From Major depressive disorder

Yes. After a first episode, the lifetime risk of a recurrence is about 50 percent. After two episodes the risk rises further. This is why ongoing care, attention to sleep and movement, and a clear plan for early relapse signs matter, even after recovery.

From Major depressive disorder

A primary care clinician can manage many cases of depression. A psychiatrist is worth involving when the diagnosis is unclear, when there is a question of bipolar disorder, when two or more medications have not worked, or when symptoms include suicidal thoughts.

From Major depressive disorder

Persistent depressive disorder (PDD), formerly called dysthymia, is depressed mood most of the day, more days than not, for at least two years in adults (one year in children and adolescents), along with at least two other symptoms. Symptom-free periods of more than two months at a time exclude the diagnosis.

From Persistent depressive disorder

Major depressive disorder is defined by discrete episodes lasting at least two weeks. PDD is defined by a chronic, lower-grade pattern lasting years. A meaningful share of patients have both at once, which is sometimes called double depression. Recognizing the underlying chronic pattern matters because treatment usually needs to continue past the resolution of any single episode.

From Persistent depressive disorder

About 1.5 percent of U.S. adults meet criteria in a given year. Lifetime prevalence is near 2.5 percent (NIMH). Rates are higher in women and in people with early onset.

From Persistent depressive disorder

PDD responds to the same general treatments as major depressive disorder: antidepressants and structured psychotherapy. CBASP (Cognitive Behavioral Analysis System of Psychotherapy) was developed specifically for chronic depression and has evidence in this group. Because the pattern is long-standing, treatment often takes longer to show its full effect.

From Persistent depressive disorder

Yes. Because PDD often starts early in life, patients often assume the way they feel is just who they are. A careful clinical history that asks about how a person felt in their teens, twenties, and the years since is the central tool for catching it.

From Persistent depressive disorder

The baby blues are a short period of tearfulness, mood swings, and worry in the first two weeks after birth that resolves on its own. Postpartum depression lasts longer, is more severe, and interferes with caring for the baby or oneself. Symptoms beyond two weeks deserve clinical attention.

From Postpartum depression

The DSM-5-TR peripartum specifier covers episodes that begin during pregnancy or within four weeks of delivery. In practice, ACOG and most clinicians screen and treat depressive episodes through the first postpartum year.

From Postpartum depression

Several antidepressants, including sertraline and paroxetine, are considered compatible with breastfeeding and have the most reassuring data. The decision is individual and is made with a clinician who knows the full picture, including the medication, the dose, the infant's age, and the mother's history.

From Postpartum depression

Brexanolone (a 60-hour intravenous infusion) and zuranolone (a 14-day oral course) are newer medications studied specifically in postpartum depression. Both target a different brain receptor system than standard antidepressants. They are options to discuss with a psychiatrist, especially when faster onset is needed.

From Postpartum depression

Any thoughts of harming the baby or harming oneself are a reason to call 988 or to go to the nearest emergency department. Postpartum psychosis, which involves confusion, hallucinations, or delusions, is a separate condition and is always a psychiatric emergency.

From Postpartum depression

Seasonal depression, clinically called major depressive disorder with seasonal pattern, is a depressive episode that recurs at the same time each year, most often in fall and winter, with full remission in spring and summer. The pattern must repeat for at least two years to meet criteria.

From Seasonal depression

In addition to standard depression symptoms, seasonal depression often includes oversleeping, increased appetite (especially for carbohydrates), weight gain, and a heavy, slowed feeling. Energy is low and motivation drops. The pattern usually begins in late fall as daylight shortens.

From Seasonal depression

Yes. Bright light therapy, typically 10,000 lux for 20 to 30 minutes within an hour of waking, has evidence comparable to antidepressants for fall-onset seasonal depression. A standard light box, used on most days through the affected months, is the clinical recommendation.

From Seasonal depression

When light therapy alone is not enough, when symptoms are moderate to severe, or when daily functioning is meaningfully affected, antidepressants (often an SSRI) and cognitive behavioral therapy adapted for seasonal depression (CBT-SAD) both have evidence. A combination is common in clinical practice.

From Seasonal depression

Yes, though it is less common than winter pattern. Summer-pattern seasonal depression can include insomnia, agitation, and reduced appetite rather than the oversleeping and overeating of winter pattern. Treatment is more often medication and therapy than light therapy.

From Seasonal depression

Bipolar depression looks identical to major depressive disorder during the depressive episodes. The difference is the rest of the picture. People with bipolar disorder also have, at some point in life, episodes of mania (bipolar I) or hypomania (bipolar II). The history is the key, not the current low mood.

From Bipolar depression

Standard antidepressants alone can sometimes destabilize bipolar disorder, triggering mood elevation, mixed states, or rapid cycling. Bipolar depression usually requires a mood stabilizer or a specific antipsychotic with evidence in bipolar depression, sometimes with an antidepressant added carefully under specialist care.

From Bipolar depression

A clinician asks about every period of unusually elevated mood, racing thoughts, decreased need for sleep, faster speech, riskier decisions, and high energy that lasted at least four days (hypomania) or seven days (mania). Family history of bipolar disorder, age of first episode, and prior medication response also matter.

From Bipolar depression

Lithium and lamotrigine are common mood stabilizers. Quetiapine, lurasidone, cariprazine, and the olanzapine-fluoxetine combination have FDA approval for bipolar depression. Choice depends on bipolar I versus II, prior response, side effects, and other conditions. A psychiatrist familiar with bipolar disorder is the right starting point.

From Bipolar depression

Sleep regularity is one of the strongest stabilizing factors in bipolar disorder. Sleep loss can trigger mood elevation. Oversleeping can extend depressive episodes. Most treatment plans include explicit attention to sleep and wake times, sometimes with a brief structured therapy called Interpersonal and Social Rhythm Therapy (IPSRT).

From Bipolar depression

About half of people with depression also meet criteria for an anxiety disorder. The combination is common enough that most clinicians screen for both whenever one is present.

From Depression with anxiety

The DSM-5-TR includes an anxious distress specifier for depressive episodes that include feeling keyed up, unusually restless, difficulty concentrating because of worry, fear that something awful may happen, or fear of losing control. The specifier flags a presentation that often needs additional attention to the anxiety component.

From Depression with anxiety

Yes. SSRIs and SNRIs are first-line for both depression and most anxiety disorders. The starting dose for anxiety is often lower, with a slower upward titration, because anxious patients can be more sensitive to early side effects. The therapeutic range is similar.

From Depression with anxiety

Benzodiazepines (alprazolam, lorazepam, clonazepam) reduce anxiety quickly but carry risks of dependence, cognitive effects, and falls, and they do not treat depression. They are sometimes used short-term while a long-term medication takes effect, and rarely as a long-term plan. A clinician should weigh the trade-offs in your specific case.

From Depression with anxiety

Cognitive behavioral therapy works for both. Some forms, including the Unified Protocol, are designed specifically for anxiety and depression together. Behavioral activation, exposure work, and mindfulness-based approaches also have evidence. A therapist who treats both is the right fit.

From Depression with anxiety

No. Grief is a normal response to loss. It tends to come in waves, is tied to reminders of the person or thing lost, and allows positive emotion in between. Major depression is more constant, is dominated by a sense of worthlessness or failure, and is less responsive to comforting circumstances. The DSM-5-TR removed the bereavement exclusion in 2013, which means a major depressive episode can be diagnosed during grief if criteria are met.

From Depression and grief

Prolonged grief disorder was added to the DSM-5-TR in 2022. It applies when intense grief, with daily yearning or preoccupation with the person who died, persists for at least twelve months in adults (six months in children and adolescents) and causes meaningful impairment. It is treated with grief-focused psychotherapy and, when indicated, medication.

From Depression and grief

When grief is not easing several months after the loss, when daily function is not returning, when there are thoughts of self-harm, or when symptoms include persistent guilt or worthlessness, an evaluation by a clinician is warranted.

From Depression and grief

Complicated Grief Treatment (CGT), a 16-session protocol developed by M. Katherine Shear and colleagues, has the strongest evidence for prolonged grief disorder and outperforms standard interpersonal psychotherapy in randomized trials (JAMA, 2005; JAMA Psychiatry, 2014). Cognitive behavioral therapy adapted for grief is also used. When a major depressive episode is present alongside grief, antidepressants treat the depression but do not, on their own, treat the grief.

From Depression and grief

Yes. The DSM-5-TR sets the duration threshold at six months in children and adolescents (versus twelve months in adults). Symptoms can include intense longing, identity disruption, withdrawal from peers, and difficulty engaging in school. A clinician with experience in pediatric bereavement is the right starting point.

From Depression and grief

Several medical conditions raise the risk of depression meaningfully, including hypothyroidism, obstructive sleep apnea, stroke, Parkinson disease, multiple sclerosis, chronic pain, cancer, and uncontrolled diabetes. Some medications, including interferon, certain steroids, and some hormonal therapies, are also associated with depressive symptoms. The relationship is two-way: depression also worsens outcomes in many medical illnesses.

From Depression related to medical illness

The treatments are similar to those for primary major depression: antidepressant medication, structured psychotherapy, and attention to sleep and activity. The choice of antidepressant is shaped by the medical condition and other medications. Treating the underlying illness, when possible, is part of the plan.

From Depression related to medical illness

Yes. Primary care clinicians screen for depression, can start treatment, and coordinate with specialists. Depression alongside a medical illness changes recovery, adherence, and quality of life, and it is reasonable to address both at the same visit.

From Depression related to medical illness

A reasonable initial workup often includes thyroid-stimulating hormone (TSH), a complete blood count, a comprehensive metabolic panel, and vitamin B12 and vitamin D levels. Sleep apnea screening is added when snoring or daytime sleepiness is present. The goal is not to find a single cause but to identify treatable contributors that can mimic or worsen depression (APA Practice Guideline, 2010).

From Depression related to medical illness

Yes. Randomized trials in patients with diabetes, coronary artery disease, and cancer have shown that treating co-occurring depression improves quality of life and self-care behaviors, and in some studies improves disease-specific outcomes such as glycemic control. Collaborative care models, in which a care manager links primary care and behavioral health, have the strongest evidence (Katon et al., NEJM, 2010).

From Depression related to medical illness

First-line treatments are psychotherapy with strong evidence (CBT, behavioral activation, interpersonal therapy), first-line antidepressants (SSRIs, SNRIs, bupropion), or a combination. For moderate to severe depression, combination treatment usually outperforms either alone.

From Treatment (overview)

Most people start to notice changes in two to six weeks, with sleep, appetite, and energy often shifting before mood does. Full benefit often takes eight to twelve weeks. The first medication tried is not always the right one.

From Treatment (overview)

About one in three people reach remission on the first medication tried, and roughly half show a meaningful response (STAR*D). Most patients need a change in dose, a switch, or an addition. That is normal and built into how we plan treatment.

From Treatment (overview)

After a first episode, most clinicians continue antidepressants for six to twelve months after symptoms resolve, then reassess. After multiple episodes, longer maintenance is often recommended. Stopping is a clinician-supervised decision because abrupt discontinuation can cause withdrawal symptoms and increases the risk of relapse.

From Treatment (overview)

When two adequate antidepressant trials at therapeutic doses for adequate duration have not produced a response, the term treatment-resistant depression often applies. Options at this point include lithium or T3 augmentation, atypical antipsychotic augmentation, esketamine, ketamine, transcranial magnetic stimulation (TMS), and, in severe cases, electroconvulsive therapy (ECT).

From Treatment (overview)

For mild to moderate depression, psychotherapy and antidepressants have similar response rates. Patient preference, prior response, the presence of significant life stressors, and access all factor into the choice. Combination treatment usually outperforms either alone for moderate to severe depression.

From Treatment (overview)

Most people start to notice changes in two to six weeks, with sleep, appetite, and energy often shifting before mood does. Full effects often take eight to twelve weeks. The first medication tried is not always the right one.

From Antidepressants

About one in three people reach remission on the first medication tried, and roughly half show a meaningful response (STAR*D). Most patients need a change in dose, a switch, or an addition. That is normal and built into how we plan treatment.

From Antidepressants

Antidepressants are not addictive in the way that opioids or benzodiazepines are. They do not produce a high, and people do not develop cravings. Stopping abruptly can cause discontinuation symptoms (flu-like feelings, brain zaps, mood changes), which is why a taper supervised by a prescriber is the standard approach.

From Antidepressants

When they work, antidepressants reduce the symptoms that have been pushing on you. Most people describe themselves as more like themselves, not less. If you feel emotionally flat or unlike yourself on a medication, that is a reason to talk to the prescriber about the dose or a different medication.

From Antidepressants

After a first episode, most clinicians continue antidepressants for six to twelve months after symptoms resolve, then reassess. After multiple episodes, longer maintenance is often recommended. The decision is individual and is made with a prescriber.

From Antidepressants

All antidepressants carry an FDA boxed warning for increased risk of suicidal thoughts in children, adolescents, and young adults up to age 25, especially in the first weeks of starting or changing a medication. Any new or worsening suicidal thoughts during this period are a reason to call a prescriber the same day.

From Antidepressants

SSRI stands for selective serotonin reuptake inhibitor. SSRIs increase the availability of serotonin in the brain by blocking its reabsorption into nerve cells. The relationship between this chemical effect and clinical improvement is more complicated than the early "chemical imbalance" framing suggested.

From SSRIs

The SSRIs in common use are sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), citalopram (Celexa), and fluvoxamine (Luvox). Vilazodone (Viibryd) and vortioxetine (Trintellix) act on serotonin in additional ways and are sometimes grouped with SSRIs and sometimes considered separately.

From SSRIs

Most people start to notice changes in two to six weeks, with sleep, appetite, and energy often shifting before mood does. Full effects often take eight to twelve weeks. The first SSRI tried is not always the right one.

From SSRIs

Common side effects include nausea, headache, sleep changes, sexual side effects (reduced libido, delayed orgasm), and a temporary increase in anxiety in the first weeks. Most settle within a few weeks. New or worsening suicidal thoughts in the first weeks are a reason to call a prescriber the same day.

From SSRIs

Weight changes vary by medication and by person. Paroxetine has the strongest association with weight gain among SSRIs. Sertraline and escitalopram tend to be more weight-neutral. Bupropion, a different class of antidepressant, is less often associated with weight gain and is sometimes associated with weight loss. Choice of medication is individual. Discuss specific concerns with a prescriber.

From SSRIs

Stopping abruptly can cause a discontinuation syndrome (flu-like feelings, brain zaps, mood changes, sleep disruption) that lasts days to weeks. A taper supervised by a prescriber is the standard approach. Paroxetine and venlafaxine (an SNRI) tend to have the most pronounced discontinuation symptoms; fluoxetine, with its long half-life, tends to have the fewest.

From SSRIs

SNRI stands for serotonin-norepinephrine reuptake inhibitor. SNRIs increase the availability of both serotonin and norepinephrine in the brain by blocking their reabsorption into nerve cells. They are first-line antidepressants alongside SSRIs.

From SNRIs

The SNRIs in common use are venlafaxine (Effexor), desvenlafaxine (Pristiq), duloxetine (Cymbalta), levomilnacipran (Fetzima), and milnacipran (Savella, used primarily for fibromyalgia). Duloxetine and venlafaxine are the most widely prescribed for depression.

From SNRIs

SSRIs act mainly on serotonin. SNRIs act on both serotonin and norepinephrine, and the norepinephrine effect becomes more prominent at higher doses. In meta-analyses, SSRIs and SNRIs have broadly similar effectiveness for depression. SNRIs are often chosen when chronic pain coexists, since duloxetine has FDA approval for several pain conditions.

From SNRIs

Common side effects include nausea, headache, sweating, dry mouth, sleep changes, sexual side effects, and a rise in blood pressure (especially with venlafaxine at higher doses). Most settle within a few weeks. Blood pressure is checked periodically, particularly when titrating venlafaxine above 150 mg per day.

From SNRIs

No. Venlafaxine in particular can produce a pronounced discontinuation syndrome (flu-like feelings, brain zaps, mood changes) if stopped abruptly because of its short half-life. A taper supervised by a prescriber, sometimes over weeks to months, is the standard approach.

From SNRIs

Bupropion (Wellbutrin) is an antidepressant that acts on dopamine and norepinephrine rather than serotonin. It is FDA-approved for major depressive disorder, seasonal affective disorder, and (under the brand name Zyban) smoking cessation. It is often used when anhedonia, low motivation, or fatigue are prominent.

From Bupropion

Bupropion does not act on serotonin, so it tends not to cause the sexual side effects, weight gain, or emotional blunting that some patients have on SSRIs. It can be activating, which makes it useful for low energy but less suitable for patients with prominent anxiety or insomnia.

From Bupropion

Common side effects include dry mouth, insomnia, headache, nausea, and a small rise in blood pressure. Anxiety or jitteriness can occur, especially early on. Bupropion is associated with a small dose-dependent increase in seizure risk, which is why it is avoided in patients with active eating disorders or a history of seizures.

From Bupropion

No. Bupropion is one of the few antidepressants associated with weight loss rather than weight gain in clinical trials, particularly at the higher dose range. This is one reason it is sometimes preferred when weight is a concern.

From Bupropion

Bupropion is commonly added to an SSRI or SNRI when the first medication is not enough on its own (a strategy known as combination therapy). The combination is generally well tolerated, and bupropion can offset the sexual side effects of SSRIs. Combinations should be supervised by a prescriber.

From Bupropion

Psychotherapy, often called talk therapy, is a structured treatment delivered by a trained clinician that uses conversation to address mental health conditions. For depression, the forms with the strongest evidence are cognitive behavioral therapy (CBT), behavioral activation, interpersonal therapy (IPT), and problem-solving therapy.

From Psychotherapy

CBT, behavioral activation, and interpersonal therapy have the strongest research evidence for depression and are recommended as first-line by APA and NICE. Choice between them depends on what is driving the episode, patient preference, and clinician training. The fit with the therapist is one of the strongest predictors of outcome.

From Psychotherapy

For evidence-based therapies, most people see meaningful change in 12 to 20 sessions. Some people benefit from longer, especially with chronic patterns or trauma. If there is no change at all by the eighth session, it is reasonable to discuss the plan with the therapist or seek a second opinion.

From Psychotherapy

For mild to moderate depression, psychotherapy and antidepressants have similar response rates. For moderate to severe depression, the combination usually outperforms either alone. Therapy also has evidence for relapse prevention after recovery, especially mindfulness-based cognitive therapy (MBCT).

From Psychotherapy

For most people with depression, telehealth therapy is comparable in effectiveness to in-person care. Telehealth widens access. In-person care can help when the home environment is a barrier or when telehealth is not a fit for technical or comfort reasons.

From Psychotherapy

Cognitive behavioral therapy (CBT) is a structured, time-limited talk therapy that targets the patterns of thinking and behavior that maintain depression. Sessions are active and skill-based. Homework between sessions is part of how it works. CBT has the strongest research evidence of any psychotherapy for depression.

From Cognitive behavioral therapy (CBT)

CBT is more structured, more present-focused, and more skills-based than open-ended supportive or psychodynamic therapy. A typical course is 12 to 20 weekly sessions with a clear plan. The therapist teaches specific tools and works with you to apply them between sessions.

From Cognitive behavioral therapy (CBT)

A standard course of CBT for depression is 12 to 20 sessions. Some people see meaningful change earlier. Some need longer, especially when there is a chronic pattern, a co-occurring condition, or trauma in the picture.

From Cognitive behavioral therapy (CBT)

For mild to moderate depression, CBT and antidepressants have similar response rates. For moderate to severe depression, the combination usually outperforms either alone. CBT also has evidence for relapse prevention after recovery, especially mindfulness-based cognitive therapy (MBCT).

From Cognitive behavioral therapy (CBT)

Self-guided CBT workbooks (David Burns' "Feeling Good," Christine Padesky and Dennis Greenberger's "Mind Over Mood") and digital CBT programs have evidence for mild to moderate depression. They are not a substitute for in-person care for severe depression, but they can be a useful starting point or supplement.

From Cognitive behavioral therapy (CBT)

Behavioral activation is a structured therapy that targets the loss of activity and reward in depression. Instead of waiting to feel better before doing more, the person and therapist identify activities that used to bring meaning or pleasure, schedule them in small steps, and notice the effect. It has evidence on par with full CBT for depression.

From Cognitive behavioral therapy (CBT)

Behavioral activation is a structured psychotherapy that targets the loss of activity and reward in depression. Instead of waiting to feel better before doing more, the patient and therapist identify activities that used to bring meaning or pleasure, schedule them in small steps, and track the effect on mood.

From Behavioral activation

Full cognitive behavioral therapy includes both behavioral and cognitive components (changing thinking patterns and changing behavior). Behavioral activation focuses on the behavioral component alone. In head-to-head trials it has shown effectiveness on par with full CBT for depression, while being simpler and more scalable.

From Behavioral activation

A standard course is 8 to 16 weekly sessions. Many people notice changes in the first few weeks as small, scheduled activities begin to shift mood. A clinician adjusts pacing based on severity and response.

From Behavioral activation

Yes. Behavioral activation has evidence in severe and chronic depression as well as in mild and moderate cases. It is sometimes paired with medication for moderate to severe presentations.

From Behavioral activation

Self-guided behavioral activation, often using a workbook or a digital program, has evidence for mild to moderate depression. Start by listing valued activities you have stopped doing, schedule one small version of one activity per day, and track mood before and after. It is not a substitute for clinical care for severe depression or for active suicidal thoughts.

From Behavioral activation

Medication management is the ongoing care of antidepressant treatment by a prescriber. It includes selecting a medication, adjusting the dose, monitoring side effects and response, screening for safety issues including suicidal thoughts, and deciding when to continue, switch, or stop. It is usually delivered by a psychiatrist, primary care clinician, or psychiatric nurse practitioner.

From Medication management

When starting a new medication, visits are usually every two to four weeks until a stable dose is reached. After that, visits are typically every one to three months. Stable patients on long-term maintenance may be seen every three to six months. Visits are shorter than therapy sessions, often 15 to 30 minutes.

From Medication management

Many patients with moderate to severe depression do best with both. A prescriber manages the medication. A therapist provides the structured psychotherapy. The two clinicians coordinate when needed. Some psychiatrists provide both, but most current practice splits the roles.

From Medication management

A primary care clinician can manage many cases of depression and is the most accessible starting point. For more complex cases, two or more failed medications, or a question of bipolar disorder, a psychiatrist or psychiatric nurse practitioner is the right next step. The Psychology Today directory and most insurance directories filter for prescribers.

From Medication management

A psychiatric evaluation is a structured first appointment with a psychiatrist or psychiatric nurse practitioner that gathers a full picture of the symptoms, the history, and the contributing factors. It usually lasts 60 to 90 minutes and ends with an initial diagnosis and a treatment plan.

From Psychiatric evaluation

The clinician asks about the current symptoms, when they started, and how they are affecting daily life. They review past psychiatric and medical history, family history, medications, substance use, sleep, and any history of trauma. A safety assessment is part of the visit. Standardized scales such as the PHQ-9 and GAD-7 are often used.

From Psychiatric evaluation

Bring a list of current medications and supplements with doses, a brief timeline of when symptoms started and what has changed, any prior diagnoses and treatments, and any recent labs or imaging. If you have a trusted family member or partner, their observations can be valuable, especially around sleep, energy, and mood patterns.

From Psychiatric evaluation

In the United States, the Mental Health Parity and Addiction Equity Act requires most insurance plans that cover mental health care to do so on terms comparable to medical care. Coverage details vary by plan. Confirm in-network status, copay, and any pre-authorization requirements with your insurer before the appointment.

From Psychiatric evaluation

A primary care clinician can manage many cases of depression. A psychiatrist is worth involving when the diagnosis is unclear, when there is a question of bipolar disorder, when two or more medications have not worked, when symptoms are severe, or when there are suicidal thoughts.

From Psychiatric evaluation

Treatment-resistant depression most often refers to a major depressive episode that has not responded to two adequate trials of antidepressants from different classes, each at a therapeutic dose for an adequate duration (usually six to eight weeks). The definition is clinical, not formal in the DSM-5-TR.

From Treatment-resistant depression

Roughly one in three patients with major depressive disorder do not reach remission after two adequate medication trials, which is the practical definition of treatment-resistant depression (STAR*D, 2006). Most of these patients still respond to further changes in the plan.

From Treatment-resistant depression

Options include lithium or T3 augmentation, atypical antipsychotic augmentation (aripiprazole, quetiapine, brexpiprazole, cariprazine), the olanzapine-fluoxetine combination, esketamine (Spravato) nasal spray, intravenous ketamine, transcranial magnetic stimulation (TMS), and, for the most severe or urgent cases, electroconvulsive therapy (ECT).

From Treatment-resistant depression

ECT remains the most effective treatment available for severe and treatment-resistant depression, with response rates of roughly 60 to 80 percent in carefully selected patients. Modern ECT is done under brief anesthesia, is much better tolerated than older techniques, and is used when other treatments have failed or when speed of response matters.

From Treatment-resistant depression

Repetitive transcranial magnetic stimulation (rTMS) has FDA approval for treatment-resistant depression. Response rates are roughly 40 to 60 percent and remission rates are roughly 25 to 40 percent in this population. Treatment is typically daily sessions over four to six weeks. It is well tolerated and does not require anesthesia.

From Treatment-resistant depression

Relapse is the return of a depressive episode after a period of improvement but before full recovery is established (usually within the first six months of remission). Recurrence is the term for a new episode after full recovery. Both are common and are tracked in treatment planning.

From Relapse

After a first episode of major depressive disorder, the lifetime risk of recurrence is about 50 percent. After two episodes the risk rises to about 70 percent, and after three episodes to about 90 percent (APA Practice Guideline). This is why ongoing care matters even after recovery.

From Relapse

Common early signs include changes in sleep that return, loss of interest in activities that had been enjoyable again, increasing isolation, slipping on basic routines, and the return of guilt or hopelessness thoughts. A written list of personal early signs, shared with a clinician and a trusted person at home, is one of the most useful relapse prevention tools.

From Relapse

Continuing antidepressants for at least six to twelve months after symptoms resolve, structured maintenance therapy when indicated, mindfulness-based cognitive therapy (MBCT) for patients with three or more prior episodes, sleep regularity, regular movement, and a written relapse plan all have evidence.

From Relapse

Contact your prescriber or therapist promptly. Restarting or adjusting treatment early in a relapse is more effective and faster than waiting for a full episode to develop. If suicidal thoughts return with intent or a plan, call or text 988, call 911, or go to the nearest emergency department.

From Relapse

Remission is the resolution of a depressive episode to a near-normal level of symptoms. Operationally, remission is often defined as a PHQ-9 score below 5 or a comparable threshold on a clinician-rated scale. Recovery is the term for sustained remission, usually for at least four to six months.

From Remission

Response means a meaningful reduction in symptoms (often a 50 percent drop on a rating scale). Remission means symptoms are essentially gone. Patients who reach remission have lower relapse rates and better functioning at work, school, and in relationships than patients who only reach response.

From Remission

About one in three patients with major depressive disorder reach remission on the first medication tried, and about half show a meaningful response (STAR*D, 2006). Most patients who do not remit on the first medication respond to a switch, a dose change, or an addition. With persistent care, most people reach remission.

From Remission

After a first episode, most clinicians continue antidepressants for six to twelve months after symptoms resolve and then reassess. After multiple episodes, longer maintenance is often recommended. Stopping is a clinician-supervised decision because abrupt discontinuation increases the risk of relapse.

From Remission

988 is the Suicide and Crisis Lifeline in the United States. It is reached by call or text, around the clock, from any phone. Veterans can press 1 to reach the Veterans Crisis Line. Spanish-language service is available by pressing 2.

From Suicide and crisis (overview)

In most calls, no. 988 counselors are trained to help by phone or text and resolve the great majority of calls without sending anyone. In rare situations of imminent danger, emergency services may be dispatched. You can ask the counselor about local options at any point in the call.

From Suicide and crisis (overview)

Ask directly. Asking about suicide does not plant the idea. Listen without arguing. Stay present. Help them connect to 988, to their clinician, or to an emergency department. If you are with someone in immediate danger, call 911. Do not leave them alone, and reduce access to lethal means.

From Suicide and crisis (overview)

A safety plan, made with a clinician, is a written list of warning signs, internal coping steps, people and places that distract, people to contact for help, professionals and agencies, and ways to make the environment safer. The Stanley-Brown Safety Planning Intervention has evidence for reducing suicide attempts after a crisis (JAMA Psychiatry, 2018).

From Suicide and crisis (overview)

Most suicide attempts are decided on within an hour of acting. Putting time and distance between a person and a lethal method (especially firearms and stockpiles of medication) reduces both the chance of an attempt and the chance that an attempt will be fatal. Means restriction is one of the strongest interventions we have.

From Suicide and crisis (overview)

Passive suicidal thoughts are wishes to die without intent or a plan. Active suicidal thoughts include intent or a plan. Both deserve clinical attention. Active thoughts with intent or a plan are a reason to call 988 or to go to the nearest emergency department now.

From Suicide and crisis (overview)

The Stanley-Brown Safety Planning Intervention is a brief, structured plan developed by Barbara Stanley and Gregory Brown that walks through six categories of coping and support to use during a suicidal crisis. It is the most widely used safety plan template in U.S. clinical settings.

From Safety plan (how-to page)

Yes. In a randomized study of patients seen in the emergency department for suicidality, the Stanley-Brown Safety Planning Intervention with structured follow-up was associated with about half the rate of suicidal behavior over six months compared with usual care (Stanley, Brown, et al., JAMA Psychiatry, 2018).

From Safety plan (how-to page)

A safety plan is most effective when made with a clinician, because the conversation surfaces warning signs and supports that are easy to miss alone. The template on this page can be filled in on your own as a starting point, then reviewed with a therapist, prescriber, or 988 counselor.

From Safety plan (how-to page)

Means safety is about putting time and distance between the person and a lethal method. For firearms, this means off-site storage with a relative, a friend, a gun shop, or a police department. For medications, it means giving stockpiles to a trusted person and keeping only a limited supply at home. Most attempts are decided on within an hour, which is why means restriction is one of the strongest interventions in suicide prevention.

From Safety plan (how-to page)

Review the plan at least every few months and after any crisis. Phone numbers change, contacts move away, and personal warning signs evolve. A plan that is six months out of date is harder to follow under stress. Bring the plan to clinical visits so it can be updated together.

From Safety plan (how-to page)

Stay present without trying to fix. Listen. Ask what helps and what does not. Offer specific help (a meal, a ride to an appointment, a walk together) rather than open-ended offers. Encourage treatment without nagging. Your steady presence over time is one of the strongest protective factors.

From Support person guide

Yes. Asking about suicide does not plant the idea; the research on this is consistent (Dazzi et al., 2014). Direct questions like "Are you thinking about ending your life?" give the person permission to talk and give you the information you need to help. Listen without arguing. Help them connect to 988 or to their clinician.

From Support person guide

Stay with them. Help them connect to 988 (call or text) or to their clinician. If they are in immediate danger, call 911. Reduce access to lethal means, especially firearms and stockpiled medication. Do not promise secrecy. Means restriction is one of the strongest interventions we have.

From Support person guide

Caregiver burden is real. Keep your own clinician, therapist, or support group in the picture. NAMI Family Support Groups are free, peer-led, and meet in most communities and online. Set realistic limits on what you can do. You are most useful to the person you support when you are not running on empty.

From Support person guide

Avoid "snap out of it," "everyone gets sad," "you have so much to be grateful for," and any version of comparing their pain to others. Avoid pressing them to explain why they feel this way. Depression is a clinical condition, not a choice. The most useful response is presence, specific help, and gentle encouragement to get and continue care.

From Support person guide

Suicidal ideation is thinking about, considering, or planning suicide. Clinicians distinguish passive ideation (a wish to be dead without a plan or intent) from active ideation (intent or a plan). Both deserve clinical attention; active ideation with intent or a plan is an emergency.

From Suicidal ideation (definition)

Active intent, a plan, access to means, or a recent attempt is a reason to call or text 988, call 911, or go to the nearest emergency department now. If you are with someone in immediate danger, do not leave them alone and reduce access to lethal means.

From Suicidal ideation (definition)

About 12.3 million U.S. adults reported serious thoughts of suicide in the past year (SAMHSA, 2022). Lifetime prevalence in major depressive disorder is substantially higher. Asking about suicide does not plant the idea; research consistently shows that asking is safe and is the first step in a safety plan.

From Suicidal ideation (definition)

A clinical assessment covers the frequency, intensity, and duration of thoughts, presence of intent or a plan, access to means (especially firearms and stockpiled medication), prior attempts, protective factors, and reasons for living. The Columbia Suicide Severity Rating Scale (C-SSRS) is one common tool.

From Suicidal ideation (definition)

Treating the underlying depression, a written safety plan made with a clinician, means restriction (especially firearms), follow-up contact after an emergency visit, and certain medications including lithium and clozapine in selected patients have evidence. The Stanley-Brown Safety Planning Intervention reduces suicide attempts after a crisis (JAMA Psychiatry, 2018).

From Suicidal ideation (definition)

Passive suicidal thoughts are wishes to be dead, to not wake up, or to disappear, without intent to act and without a plan. They are a recognized symptom of major depressive disorder and are common during severe episodes. They sit on the milder end of the suicidal-thinking spectrum but still deserve clinical attention.

From Passive suicidal thoughts

Passive thoughts without intent or a plan are usually not an emergency, but they are a reason to talk to a clinician promptly. They can shift toward active thoughts during a worsening episode, and they belong in any conversation with a prescriber or therapist.

From Passive suicidal thoughts

Yes. Bringing up passive thoughts gives a clinician important information about severity and informs the treatment plan, including the choice of medication, the pace of follow-up, and the value of a written safety plan. Talking about these thoughts does not increase risk.

From Passive suicidal thoughts

Active suicidal thoughts include intent, a plan, or steps toward acting (acquiring means, choosing a time or place). Any movement from "I wish I were not here" toward intent or planning is a reason to contact a clinician the same day, call or text 988, or go to the nearest emergency department.

From Passive suicidal thoughts

Active suicidal thoughts include intent to act, a plan, or steps toward acting (acquiring means, choosing a time or place). They are distinguished from passive thoughts (wishes to be dead without intent or a plan) and are a clinical emergency.

From Active suicidal thoughts

Call or text 988, call 911, or go to the nearest emergency department now. If you are with someone, tell them. Reduce access to lethal means immediately, especially firearms and stockpiled medication. You do not have to be certain you would act to ask for help.

From Active suicidal thoughts

A clinical assessment covers intent, a plan, access to means, timing, prior attempts, protective factors, and reasons for living. Validated tools such as the Columbia Suicide Severity Rating Scale (C-SSRS) help structure the conversation. The result guides whether to treat in the community, intensify outpatient care, or hospitalize.

From Active suicidal thoughts

Stay with them. Help them connect to 988 or to their clinician. If they are in immediate danger, call 911. Reduce access to lethal means. Do not promise secrecy. Asking directly about suicide does not plant the idea and is the first step in keeping someone safe.

From Active suicidal thoughts

A safety plan is a brief written plan, made with a clinician, that lists warning signs, internal coping steps, people and places that distract, people to contact for help, professional and crisis contacts, and ways to make the environment safer. The Stanley-Brown Safety Planning Intervention is the most widely used template.

From Safety plan (definition)

Yes. In a randomized study of patients seen in the emergency department for suicidality, the Stanley-Brown Safety Planning Intervention with structured follow-up was associated with about half the rate of suicidal behavior over six months compared with usual care (JAMA Psychiatry, 2018).

From Safety plan (definition)

The standard six steps are: (1) personal warning signs; (2) internal coping strategies you can do alone; (3) social contacts and settings that provide distraction; (4) people you can ask for help; (5) professionals and crisis lines including 988 and your clinician; and (6) means safety steps to reduce access to firearms and stockpiled medication.

From Safety plan (definition)

Most suicide attempts are decided on within an hour of acting. Putting time and distance between a person and a lethal method, especially firearms and stockpiles of medication, reduces both the chance of an attempt and the chance that an attempt will be fatal. Means restriction is one of the strongest single interventions in suicide prevention.

From Safety plan (definition)

A safety plan should be reviewed at least every few months and after any crisis. Phone numbers change, contacts move away, and personal warning signs evolve. A plan that is six months out of date is harder to follow under stress.

From Safety plan (definition)

The strongest day-to-day anchors are sleep regularity (same wake time, even on weekends), regular movement (walking counts), connection with at least one other person most days, and basic structure (meals at roughly the same times). These do not replace treatment, but they make treatment work better.

From Living with depression

Yes. Regular exercise has evidence comparable to medication for mild to moderate depression. Both aerobic exercise and resistance training help. The hardest part is starting. A small daily walk has more evidence than a perfect plan you do not follow.

From Living with depression

There is no single right answer. The Americans with Disabilities Act protects against discrimination based on a known disability and can support reasonable accommodations. You are not required to disclose a diagnosis to ask for accommodations, only to provide documentation of need. A clinician or HR contact can help think through what to share.

From Living with depression

Common early signs include changes in sleep that return, loss of interest in activities that had been enjoyable again, increasing isolation, slipping on basic routines, and the return of guilt or hopelessness thoughts. A written list of personal early signs is a useful tool to share with a clinician and a trusted person at home.

From Living with depression

Stay present without trying to fix. Listen. Ask what helps and what does not. Offer specific help (a meal, a ride to an appointment, a walk together) rather than open-ended offers. Encourage treatment without nagging. If you are worried about safety, ask directly about suicidal thoughts.

From Living with depression

Start with the type of help you want (therapy, medication, or both), then narrow by insurance, location or telehealth availability, and area of focus. Most therapists offer a brief consultation call. The fit between you and the therapist is one of the strongest predictors of how well therapy works.

From How to find a therapist

A therapist provides talk therapy. Psychiatrists are physicians (MD or DO) who can diagnose, prescribe medication, and often provide therapy. Psychologists (PhD or PsyD) hold doctorates in psychology and provide therapy and psychological testing. LCSWs, LMFTs, and LPCs are master's-level licensed therapists.

From How to find a therapist

Options include sliding-scale therapists, community mental health centers, federally qualified health centers, training clinics at universities, employee assistance programs (EAPs), and online directories that filter by sliding scale. Open Path Collective and Inclusive Therapists list lower-fee options. Your state's 211 line can help locate local resources.

From How to find a therapist

Both are effective for most people with depression. Telehealth widens access, especially in areas with few clinicians. In-person care can help when the home environment is a barrier, when you want a quiet space outside the house, or when telehealth is not a fit for technical or comfort reasons.

From How to find a therapist

Ask about training, experience with depression, the type of therapy they practice, expected length of treatment, fees and insurance, what a typical session looks like, and how they handle a crisis. A clinician should welcome these questions on a first call.

From How to find a therapist

For evidence-based therapies for depression (CBT, behavioral activation, interpersonal therapy), most people see meaningful change in 12 to 20 sessions. Some people benefit from longer, especially with chronic patterns or trauma. If there is no change at all by the eighth session, it is a reason to discuss the plan with the therapist or seek a second opinion.

From How to find a therapist

The PHQ-9 (Patient Health Questionnaire-9) is a nine-item depression screen used in primary care, mental health clinics, and research. Each item is scored 0 to 3, for a total of 0 to 27. Scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression. The PHQ-9 is a screen, not a diagnosis.

From Screening tools (PHQ-9 and others)

Yes. The U.S. Preventive Services Task Force recommends screening for depression in the general adult population, including pregnant and postpartum people. The USPSTF gave this a Grade B recommendation, meaning there is moderate certainty of moderate net benefit.

From Screening tools (PHQ-9 and others)

A score of 5 to 9 suggests mild depression. 10 to 14 suggests moderate depression. 15 to 19 suggests moderately severe depression. 20 or higher suggests severe depression. A positive score is a reason to talk to a clinician for a full evaluation, not a diagnosis on its own.

From Screening tools (PHQ-9 and others)

The GAD-7 (Generalized Anxiety Disorder-7) is a seven-item anxiety screen often paired with the PHQ-9. The same scoring scale (0 to 21) flags mild, moderate, and severe anxiety at thresholds of 5, 10, and 15. Many depression evaluations include both.

From Screening tools (PHQ-9 and others)

The Edinburgh Postnatal Depression Scale (EPDS) is the most widely used screen during pregnancy and the postpartum period. ACOG and the American Academy of Pediatrics recommend screening at least once during the perinatal period, with many practices screening at every prenatal visit and at well-child visits during the first postpartum year.

From Screening tools (PHQ-9 and others)

For an immediate crisis, call or text 988 (the Suicide and Crisis Lifeline) or call 911. For an urgent but non-emergency evaluation, a primary care visit is usually the fastest route, often available within a week. For ongoing therapy, the Psychology Today directory is the most widely used way to filter by location, insurance, and specialty.

From Resources hub

Options include sliding-scale therapists, community mental health centers, federally qualified health centers, training clinics at universities, employee assistance programs (EAPs), and online directories that filter by sliding scale (Open Path Collective, Inclusive Therapists). Your state's 211 line can help locate local resources.

From Resources hub

SAMHSA's National Helpline (1-800-662-HELP) provides free, confidential, 24-hour referrals for mental health and substance use. FindTreatment.gov searches treatment facilities by location and insurance. Federally qualified health centers offer sliding-scale care regardless of insurance. The 988 Suicide and Crisis Lifeline is available by call or text.

From Resources hub

In the United States, the Mental Health Parity and Addiction Equity Act of 2008 requires most insurance plans that cover mental health care to do so on terms comparable to medical care, including copays, visit limits, and pre-authorization. Coverage details vary by plan. State insurance regulators handle parity complaints.

From Resources hub

Start with your insurer's in-network directory, but verify directly with the clinician's office because directories are often out of date. The Psychology Today directory, Headway, and Alma also filter by insurance. For psychiatric medication, ask your primary care clinician for a referral or use the same directories filtered for prescribers.

From Resources hub

The three books listed on this page are written by Shariq Refai, MD, MBA, a board-certified psychiatrist and the editor and named medical reviewer of DepressionResource.org. They are listed because they are written by the named medical reviewer and may be useful related reading.

From Books on depression

All three books are available through the author site at shariqrefai.com and through major retailers. DepressionResource.org does not sell the books and does not earn any commission from their sale. Book links go to the author's personal site.

From Books on depression

No. The author earns royalties on the sale of the books. DepressionResource.org receives no revenue from book sales. The site does not accept advertising, sponsored content, paid placements, or affiliate revenue. The decision to list the books was editorial, not commercial.

From Books on depression

No. The books are educational reading and are not a substitute for evaluation or treatment by a qualified clinician. If you are in crisis, call or text 988 or call 911. For ongoing care, work with a primary care clinician, therapist, or psychiatrist.

From Books on depression

Anhedonia is a reduced ability to feel pleasure or to anticipate pleasure. It is one of the two core symptoms of major depressive disorder in the DSM-5-TR; either anhedonia or depressed mood, present for most of the day nearly every day for at least two weeks, can anchor the diagnosis.

From Anhedonia

Patients commonly describe flatness rather than sadness. Food without taste, music without pull, sex that feels mechanical, time with family that passes without the usual lift. The motivation to start an activity often disappears before the activity itself stops feeling good.

From Anhedonia

Anhedonia is reported in roughly 70 percent of patients with major depressive disorder in clinical samples (Cao et al., 2019). It is also reported by an estimated 30 to 50 percent of people with schizophrenia and by a substantial share of people with chronic pain conditions.

From Anhedonia

Depressed mood is a present feeling of sadness or low mood. Anhedonia is the absence of pleasure or interest. Both are core symptoms of major depressive disorder, and many patients have both. Anhedonia is often slower to improve with treatment than mood.

From Anhedonia

Behavioral activation, a structured therapy that rebuilds connection to activities before the pleasure returns, is well-suited to anhedonia. Bupropion is sometimes chosen when anhedonia and low motivation dominate. Ketamine, esketamine, and other treatments studied in treatment-resistant depression have shown specific signals on anhedonia in research.

From Anhedonia

Depressed mood, in the DSM-5-TR, refers to a sustained low mood (sadness, emptiness, hopelessness) present for most of the day, nearly every day, for at least two weeks. It is one of the two core symptoms of a major depressive episode; the other is anhedonia, the loss of interest or pleasure.

From Depressed mood

Sadness is a normal response to loss or stress and tends to ease with time, comfort, and a change in circumstances. Depressed mood in major depressive disorder is more pervasive, more persistent, less responsive to comforting events, and is accompanied by other symptoms such as sleep changes, fatigue, guilt, or thoughts of death.

From Depressed mood

Yes. The DSM-5-TR allows irritable mood to substitute for depressed mood in children and adolescents. Many young people with depression appear angry or short-fused rather than sad, and missing this leads to underdiagnosis.

From Depressed mood

A low mood without the other symptoms required for major depressive disorder may reflect an adjustment reaction, grief, or a transient response to stress. It is still worth talking to a clinician if it lasts more than two weeks, interferes with daily life, or is accompanied by thoughts of self-harm.

From Depressed mood

Psychomotor slowing (also called psychomotor retardation) is a visible slowing of movement, speech, and thought that can occur during a major depressive episode. It includes slowed walking, longer pauses before answering, quieter speech, and a blunted facial expression. It is observable to others, not just felt internally.

From Psychomotor slowing

Fatigue is a felt experience of low energy. Psychomotor slowing is an observable change in the rate of movement and thought. The two often coexist but are tracked separately in clinical assessment because psychomotor slowing tends to mark more severe depression and is one of the features of melancholic depression.

From Psychomotor slowing

Yes. Marked psychomotor slowing, especially with melancholic features, often responds well to antidepressant medication, ECT, and structured care. It is one of the symptoms that argues for prompt, active treatment rather than watchful waiting.

From Psychomotor slowing

Fatigue in depression involves changes in sleep architecture, circadian rhythm, appetite and nutrition, activity level, and inflammatory signaling. The result is a heavy, body-deep tiredness that sleep does not fix. About 90 percent of patients with major depression report meaningful fatigue.

From Fatigue

Ordinary tiredness improves with rest. The fatigue of depression often does not. Patients describe waking unrefreshed, feeling effort in routine tasks, and losing the sense that activity is restorative.

From Fatigue

Hypothyroidism, anemia, vitamin B12 or vitamin D deficiency, obstructive sleep apnea, diabetes, chronic infections, and several medications (including some for blood pressure and allergies) can cause fatigue and low mood that overlap with depression. Basic blood work and a sleep history are part of a complete evaluation.

From Fatigue

Treating the underlying depression is the main lever. Sleep regularity, light morning exposure, and graded physical activity have evidence as adjuncts. Bupropion and certain SNRIs are sometimes chosen when fatigue and low energy are prominent. Modafinil is sometimes used as an add-on in selected cases.

From Fatigue

DepressionResource.org is a publication of shrinkMD Publishing Inc. The site is edited and medically reviewed by Shariq Refai, MD, MBA, a board-certified psychiatrist with more than 15 years of clinical experience and the founder of shrinkMD, a multistate telepsychiatry practice. His full profile is on the About page.

From About this site

DepressionResource.org does not accept advertisements, sponsored content, paid placements, or affiliate revenue. The editor has a financial interest in shrinkMD, which is disclosed inline on every page that names it. The editor is also the author of the books listed on the Books page and earns royalties on their sale; the site receives no revenue from book sales.

From About this site

Every clinical page is written or reviewed by Shariq Refai, MD, MBA, against current clinical guidelines from APA, NICE, ACOG, and the relevant federal agencies (NIMH, SAMHSA, CDC). Pages carry a "last reviewed" date and are reviewed at least annually. The full process is on the Medical Review Process page.

From About this site

No. DepressionResource.org provides general information for educational purposes. It does not replace evaluation or treatment by a qualified clinician. If you are in crisis, call or text 988 or call 911. For ongoing care, work with a primary care clinician, therapist, or psychiatrist.

From About this site

Send corrections, accessibility issues, privacy questions, press inquiries, or legal inquiries through the Contact page. We correct errors openly and follow the process described in the Corrections Policy.

From About this site